Glass House Farms recently launched a new 1:1 cultivar in partnership with FRB Genetics, providing the California cannabis market with a flower product that dials in the THC and CBD ratio pretty evenly. It’s called Tangelo Flo, and it’s finding its way to the market at a time when industry stakeholders and consumers are having in-depth conversations about potency, chemical profiles and minor cannabinoids.
Tangelo Flo offers a balanced cannabinoid profile (a “type-II” chemotype, in parlance that’s making its way into the commercial space, meaning one that features a mixed-ratio cannabinoid profile). Even as high-THC cultivars and products continue to top the sales charts, industry chatter is keen on a more balanced suite of chemicals. That’s where FRB Genetics’ R&D work has taken the team, led by Reggie Gaudino.
A cross of Green Crack and Cherry Wine, the new cultivar boasts approximately 31% total cannabinoids and a rich, citrus-forward mango flavor. Green Crack is a THC heavyweight, and Cherry Wine is a popular hemp variety.
Courtesy of FRB Genetics
Tangelo Flo at the Glass House Farms greenhouse.
Front Range Biosciences runs a marker-assisted hemp breeding program, and the Cherry Wine options were fairly limitless for the FRB Genetics team. (FRB Genetics licenses the breeding technology from Front Range Biosciences, which is not a plant-touching company.) Gaudino’s wanted to showcase some of the good work being done on those hemp varieties—and perhaps usher those genetics into the broader adult-use cannabis space.
The Cherry Wine side of the equation posed an interesting challenge, because Gaudino’s team was looking for a high CBD producer that could also remain compliant as a hemp variety (clocking in under 0.3% THC content). That’s no small task. This process involved thousands of seeds and countless hours spent observing the different Cherry Wine plants. They landed on an ideal phenotype, one that